Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: Pathologic, radiologic, and molecular studies

Human Gene Therapy

Volumn 7, Issue 10, 1996, Pages 1241-1250

  Goodman, J C ^a,d   Trask, T W ^a   Chen, S H ^a   Woo, S L C ^a   Grossman, R G ^a   Carey, K D ^b   Hubbard, G B ^b   Carrier, D A ^c   Rajagopalan, S ^a   Aguilar Cordova, E ^a   Shine, H D ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c WILFORD HALL MEDICAL CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; AUTOPSY; CENTRAL NERVOUS SYSTEM; EUTHANASIA; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GLIOMA; HERPES SIMPLEX VIRUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLAQUE FORMING CELL; POLYMERASE CHAIN REACTION; PRIMATE; VIRUS GENE;

ANIMALIA; HERPES; PAPIO; PAPIO SP.; PRIMATES; RODENTIA; SIMPLEXVIRUS;

EID: 19144366876     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.10-1241     Document Type: Article

References (59)

1. ABZUG, M.J., and LEVIN, M.J. (1991). Neonatal adenovirus infection: four patients and review of the literature. Pediatrics 87, 890-896.
2. AKLI, S., CAILLAUD, C., VIGNE, E., STRATFORD-PERRICAUDET, L.D., POENARU, L., PERRICAUDET, M., KAHN, A., and PESCHANSKI, M.R. (1993). Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet. 3, 224-228.
3. ALLARD, A., GIRONES, R., JUTO, P., and WADELL, G. (1990). Polymerase chain reaction for detection of adenoviruses in stool samples. J. Clin. Microbiol. 28, 2659-2667.
4. BARBA, D., HARDIN, J., RAY, J., and GAGE, F.H. (1993). Thymidine kinase-mediated killing of rat brain tumors. J. Neurosurg. 79, 729-735.
5. BARBA, D., HARDIN, J., SADELAIN, M., and GAGE, F.H. (1994). Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. USA 91, 4348-4352.
6. BETT, A.J., HADDARA, W., PREVEC, L., and GRAHAM, F.L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91, 8802-8806.
7. BLAESE, R.M., MULLEN, C.A., and RAMSEY, W.J. (1993). Strategies for gene therapy. Pathol. Biol. 41, 672-676.
8. BOVIATSIS, E.J., CHASE, M., WEI, M.X., TAMIYA, T., HURFORD, R.K., JR., KOWALL, N.W., TEPPER, R.I., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994). Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum. Gene Ther. 5, 183-191.
9. BOVIATSIS, E.J., PARK, J.S., SENA-ESTEVES, M., KRAMM, C.M., CHASE, M., EFIRD, J.T., WEI, M.X., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994). Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res. 54, 5745-5751.
10. BRODY, S.L., and CRYSTAL, R.G. (1994). Adenovirus-mediated in vivo gene transfer. Ann. NY Acad. Sci. 716, 90-101.
11. CHEN, S.H., SHINE, H.D., GOODMAN, J.C., GROSSMAN, R.G., and WOO, S.L.C. (1994). Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91, 3054-3057.
12. CHOU, S.M., ROOS, R., BURRELL, R., GUTMANN, L., and HARLEY, J.B. (1973). Subacute focal adenovirus encephalitis. J. Neuropathol. Exp. Neurol. 32, 34-50.
13. COELHO, A.M., and CAREY, K.D. (1990). A social tethering system for nonhuman primates used in laboratory research. Lab. Animal Sci. 40, 388-394.
14. COHEN, J.S. (1992). Selective anti-gene therapy for cancer principles and prospects. Tohoku J. Exp. Med. 168, 351-359.
15. COLAK, A., GOODMAN, J.C., CHEN, S., WOO, S.L.C., GROSSMAN, R.G., and SHINE, H.D. (1995). Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome. Brain Res. 691, 76-82.
16. COLAK, A., GOODMAN, J.C., CHEN, S., WOO, S.L.C., GROSSMAN, R.G., and SHINE, H.D. (1995). Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain. Hum. Gene Ther. 6, 1317-1322.
17. CULVER, K.W. (1994). Clinical applications of gene therapy for cancer. Clin. Chem. 40, 510-512.
18. CULVER, K.W., and BLAESE, R.M. (1994). Gene therapy for cancer. Trends Genet. 10, 174-178.
19. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
20. CULVER, K.W., VAN GILDER, J., LINK, C.J., CARLSTROM, T., BUROKER, T., YUH, W., KOCH, K., SCHABOLD, K., DOORNBAS, S., and WETJEN, B. (1994). Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum. Gene Ther. 5, 343-379.
21. DAVIDSON, B.L., and ROESSLER, B.J. (1995). Adenoviral-mediated gene transfer: potential therapeutic applications. In Viral Vectors - Gene Therapy and Neuroscience Applications. M.G. Kaplitt and A.D. Loewy, eds. (Academic Press, New York) pp. 173-192.
22. DORAN, S.E., ROESSLER, B.J., HARTMAN, J.W., HOFF, J.T., SHEWACH, D.S., and DAVIDSON, B.L. (1994). Adenovirus-mediated in vivo gene transfer into the central nervous system of a non-human primate. Clin. Neurosurg. 41, 242-257.
23. ECK, S.L. (1995). International Conference on Gene Therapy for CNS Disorders. University of Pennsylvania, Philadelphia, PA.
24. FREEMAN, S.M., and ZWIEBEL, J.A. (1993). Gene therapy of cancer. Cancer Invest. 11, 675-688.
25. GINSBERG, H.S., MOLDAWER, L.L., SEHGAL, P.B., REDINGTON, M., KILIAN, P.L., CHANOCK, R.M., and PRINCE, G.A. (1991). A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88, 1651-1655.
26. GRAHAM, F., and PREVEC, L. (1991). Manipulation of adenovirus vectors. Methods in Molecular Biology: Gene Transfer and Expression Protocols, vol. 7. E.J. Murray, ed. (Humana Press, Clifton, NJ) pp. 109-127.
27. HECK, F.C., JR., SHELDON, W.G., and GLEISER, C.A. (1972). Pathogenesis of experimentally produced mouse adenovirus infection in mice. Am. J. Veterin. Res. 33, 841-846.
28. HORELLOU, P., REVAH, F., SABATE, O., BUC-CARON, M.H., ROBERT, J.-J., and MALLET, J. (1995). Adenovirus: a new tool to transfer genes into the central nervous system for treatment of neurodegenerative disorders. In Genetic Manipulation of the Nervous System. D. Latchman, ed. (Academic Press, New York) pp. 41-51.
29. IZQUIERDO, M., CORTES, M., DE FELIPE, P.D., MARTIN, V., DIEZ-GUERRA, J., TALAVERA, A., and PEREZ-HIGUERAS, A. (1995). Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Ther. 2, 66-69.
30. ISRAEL, M.A. (1993). Molecular approaches to cancer therapy. Adv. Cancer Res. 61, 57-85.
31. KIPPS, T.J. (1993). Gene therapy for cancer. J. Hematother. 2, 367-372.
32. KOZARSKY, K.F., and WILSON, J.M. (1993). Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 3, 499-503.
33. KRAMM, C.M., SENA-ESTEVES, M., BARNETT, F.H., RAINOV, N.G., SCHUBACK, D.E., YU, J.S., PECHAN, P.A., PAULUS, W., CHIOCCA, E.A., and BREAKEFIELD, X.O. (1995). Gene therapy for brain tumors. Brain Pathol. 5, 345-381.
34. LE GAL LA SALLE, G., ROBERT, J.J., BERRARD, S., RIDOUX, V., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., and MALLET, J. (1993) An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259, 988-990.
35. LESSER, G.J., and GROSSMAN, S.A. (1993). The chemotherapy of adult primary brain tumors. Cancer Treatment Rev. 19, 261-281.
36. LEVY, M.L., TUNG, H., COULDWELL, W.T., HINTON, D.R., and APUZZO, M.L. (1992). Neurosurgery, molecular medicine, and the Pandora-Panacea continuum: future implications for glioma therapy? Clin. Neurosurg. 39, 421-462.
37. LOWENSTEIN, P.R., WILKINSON, G.W.G., CASTRO, M.G., SHERING, A.F., FOOKS, A.R., and BAIN, D. (1995). Non-neurotropic adenovirus: a vector for gene transfer to the brain and possible gene therapy of neurological disorders. In Genetic Manipulation of the Nervous System. D. Latchman, ed. (Academic Press, New York) pp. 1-39.
38. MINETA, T., RABKIN, S.D., and MARTUZA, R.L. (1994). Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res. 54, 3963-3966.
39. MOOLTEN, F.L. (1986). Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for prospective cancer control strategy. Cancer Res. 46, 5276-5281.
40. MOOLTEN, F.L., and WELLS, J.M. (1990). Curability of tumors bearing thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82, 297-300.
41. NEVE, R.L. (1993). Adenovirus vectors enter the brain. Trends Neurosci. 16, 251-253.
42. PACINI, D.L., DUBOVI, E.J., and CLYDE, W.A. (1974). A new animal model for human respiratory tract disease due to adenovirus. J. Infect. Dis. 150, 92-97.
43. PELLER, P., and GOETZ, O. (1971). Double infection with fatal outcome due to cytomegalovirus and adenovirus type 3 in a premature infant. Zeitschrift fur Kinderheilkunde 109, 228-236.
44. PEREZ-CRUET, M.J., TARSK, T.W., CHEN, S.-H., GOODMAN, J.C., WOO, S.L.C., GROSSMAN, R.G., and SHINE, H.D. (1994). Adenovirus-mediated gene therapy of experimental gliomas. J. Neuroscience Res. 39, 506-511.
45. RAM, Z., CULVER, K.W., WALBRIDGE, S., BLAESE, R.M., and OLDFIELD, E.H. (1993). In situ retroviral-mediated gene transfer for the treatment of brain tumors. Cancer Res. 53, 83-88.
46. RAM, Z., WALBRIDGE, S., SHAWKER, T., CULVER, K.W., BLAESE, R.M., and OLDFIELD, E.H. (1993). Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J. Neurosurg. 79, 400-407.
47. ROSENBERG, S.A. (1991). Immunotherapy and gene therapy of cancer. Cancer Res. 51 (Suppl), 5074s-5079s.
48. ROSENBERG, S.A. (1992). Gene therapy of cancer. In Important Advances in Oncology 1992. V.T. DeVita, S. Hellman, and S.A. Rosenberg, eds. (J.B. Lippincott Co., Philadelphia) pp. 17-38.
49. SHENK, T. (1995). Group c adenoviruses as vectors for gene therapy. In Viral Vectors - Gene Therapy and Neuroscience Applications. M.G. Kaplitt and A.D. Loewy, ed. (Academic Press, New York) pp. 43-54.
50. SHINE, H.D., and WOO, S.L.C. (1995). Adenovirus-mediated gene therapy of tumors in the central nervous system. In Genetic Manipulation of the Nervous System. D. Latchman, ed. (Academic Press, New York) pp. 53-71.
51. SIKORA, K. (1994). Genes, dreams, and cancer. Br. Med. J. 308, 1217-1221.
52. TAKAMIYA, Y., SHORT, M.P., EZZEDDINE, Z.D., MOOLTEN, F.L., BREAKEFIELD, X.O., and MARTUZA, R.L. (1992). Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J. Neurosci. Res. 33, 493-503.
53. TAKAMIYA, Y., SHORT, M.P., MOOLTEN, F.L., FLEET, C., MINETA, T., BREAKEFIELD, X.O., and MARTUZA, R.L. (1993). An experimental model of retrovirus gene therapy for malignant brain tumors. J. Neurosurg. 79, 104-110.
54. TSINZERLING, V.A. (1975). Lesions of the central nervous system in adenovirus infections. Arkhiv Patologii 37, 57-59.
55. VALENTINE, R.C., and PEREIRA, H.G. (1965). Antigens and structure of the adenovirus. J. Mol. Biol. 13, 13-20.
56. VIOLA, J.J., RAM, Z., WALBRIDGE, S., OSHIRO, E.M., TRAPNELL, B., TAO-CHENG, J.H., and OLDFIELD, E.H. (1995). Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells. J. Neurosurg. 82, 70-76.
57. WEI, M.X., TAMIYA, T., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1995). Virus vector-mediated transfer of drug-sensitivity genes for experimental brain tumor therapy. In Viral Vectors - Gene Therapy and Neuroscience Applications. M.G. Kaplitt and A.D. Loewy, eds. (Academic Press, New York) pp. 239-257.
58. WEST, T.E., PAPASIAN, C.J., PARK, B.H., and PARKER, S.W. (1985). Adenovirus type 2 encephalitis and concurrent Epstein-Barr virus infection in an adult man. Arch. Neurol. 42, 815-817.
59. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.